Beijing Disability Risk and Ageing Monitoring Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorXuanwu Hospital, Beijing
About this trial
This is a community-based prospective cohort study in Beijing, China. The study has been initialized in 2023 and enrolled older residents. This study aims to develop disability risk assessment standards and an early warning model for older adults.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 60 years or older
Lived in the community for more than 1 year
Signed the informed consent form
Disqualifiers
Cannot complete the survey
Trial population
Community residents aged 60 years or older in China
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
2,000 Participants
are divided into 1 treatment groupGroup A: Total1 intervention
Trial outcomes
Primary outcomes
1
The prevalence and incidence of functional disability using a population-based survey
Functional disability was measured by Activities of Daily Living, cognitive function (Mini-Mental State Examination) and movement disorder（Short Physical Performance Battery) collected by questionnaires.The minimum value of the Activities of Daily Living is 0, and the maximum value is 100, the higher the score, the better the outcome.The minimum value of the Mini-Mental State Examination is 0, and the maximum value is 30, the higher the score, the better the outcome.The minimum value of the Short Physical Performance Battery is 0, and the maximum value is 12, the higher the score, the better the outcome.
Time frame
An average of 1 to 2 years2
The prevalence and incidence of mild cognitive impairment using a population-based survey
Mild cognitive impairment was measured using Mini-Mental State Examination collected by questionnaire.The minimum value of the Mini-Mental State Examination is 0, and the maximum value is 30, the higher the score, the better the outcome.
Time frame
An average of 1 to 2 years3
The prevalence and incidence of dementia using a population-based survey
Dementia was determined by diagnosis of hospitalization or diagnosis of death or Clinical Dementia Rating scale. The minimum value of the Clinical Dementia Rating is 0, and the maximum value is 3, the higher the score, the worse the outcome.
Time frame
An average of 1 to 2 years4
The conversion rate of normal to mild cognitive impairment
Percentage of enrolled population that convert from normal to mild cognitive impairment
Time frame
An average of 1 to 2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov